6 7 September 2006 - PowerPoint PPT Presentation

1 / 10
About This Presentation
Title:

6 7 September 2006

Description:

United Nations Educational, Scientific and Cultural Organization ... The Case of Pascual Laboratories. Pascual Laboratories exists as a drug manufacturer since 80's ... – PowerPoint PPT presentation

Number of Views:34
Avg rating:3.0/5.0
Slides: 11
Provided by: pes
Category:

less

Transcript and Presenter's Notes

Title: 6 7 September 2006


1
HERBAL MEDICINE
Group 3
6 7 September 2006 Astoria Plaza, Pasig City,
Philippines
2
Group Members
  • Mr. Milo Aguila
  • Ms. Mayet Jayloni
  • Ms. Jelina Tetangco

3
Case Market Expansion of Herbal Medicines
The Case of Pascual Laboratories
I. Brief Description of the case lead
  • Pascual Laboratories exists as a drug
    manufacturer since 80s
  • Year 2000 acquired proprietary rights as DOST
    developed
  • medicinal plant production technologies
    (Lagundi and
  • Sambong tablets) thru PCHRD-DOST
  • Year 2005 started exporting medicinal plant
    products to US
  • Germany
  • Current Status 2nd term renewal of licensing
    agreement

4
II. Brief Statement of Learning Objectives
  • To determine if there was a significant impact
    (good bad) of DOST
  • Technologies to the entrepreneur
  • To describe the hardships, failures and other
    events when the company
  • is still starting
  • To determine the challenges that they were able
    to overcome
  • To determine the success factors of their
    endeavor
  • To determine the government policies or/and
    interventions that helped
  • or hinder them

5
III. Proposed Outline
  • Overview/Brief Description
  • Company background
  • Corporate Social Responsibility Aspect
  • Nature of business
  • Management setup and organization structure
  • Profile/Portfolio
  • Before they acquire the technology
  • During/after the technology acquisition

6
III. Proposed Outline
  • 4. Specific Area or Areas of Interest
  • Domestic market ? barangay level/use of the
    medicinal plant
  • products
    in the primary health care
  • International market ?other export opportunities
    in Europe

  • others
  • 5. Problems and Difficulties Encountered
  • Product acceptability
  • Product quality, safety and efficacy
  • Competitiveness of the product
  • Market Forces

7
III. Proposed Outline
  • 6. Relevant government policies and
    interventions
  • DOST Technology Transfer mechanism (MC001)
  • Regulatory Concerns
  • Marketing Concerns (Ethical Drugs) including
    Advertising
  • 7. Conclusion /Concluding Statement
  • Domestic market expansion I.e. primary health
    care/corporate
  • social responsibility
  • OR potential/pursue export

8
IV. Data Requirement List
  • Company Profile
  • Financial Statements
  • Experiences in technology adoption
  • Government policies/restrictions/interventions
  • Strategic Plan/Medium Term Plan of the Company
  • Contracts/Memorandum of Agreements/Licensing
    Agreements

9
V. Proposed Schedule
  • Identification of the case study themes
  • Search for case lead
  • Preparation review of case plans 2 months
  • approval of the case plan
  • -- identification of stockholders
  • -- methodology
  • -- instrument to be used
  • data gathering

10
V. Proposed Schedule
  • Case writing - 2 months
  • draft submission
  • Draft revisions
  • Finalization of the case
  • Case review - 1 month
  • Case Rewriting - 1 month
Write a Comment
User Comments (0)
About PowerShow.com